Cargando…
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
Regarding breast cancer treatment, triple negative breast cancer (TNBC) is a difficult issue. Most TNBC patients die of cancer metastasis. Thus, to develop a new regimen to attenuate TNBC metastatic potential is urgently needed. MART-10 (19-nor-2α-(3-hydroxypropyl)-1α,25(OH)(2)D(3)), the newly-synth...
Autores principales: | Chiang, Kun-Chun, Yeh, Ta-Sen, Chen, Shin-Cheh, Pang, Jong-Hwei S., Yeh, Chun-Nan, Hsu, Jun-Te, Chen, Li-Wei, Kuo, Sheng-Fong, Takano, Masashi, Kittaka, Atsushi, Chen, Tai C., Sun, Chi-Chin, Juang, Horng-Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849057/ https://www.ncbi.nlm.nih.gov/pubmed/27110769 http://dx.doi.org/10.3390/ijms17040606 |
Ejemplares similares
-
MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells
por: Chiang, Kun-Chun, et al.
Publicado: (2012) -
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
por: Yang, Shih-Wei, et al.
Publicado: (2016) -
MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
por: Chiang, Kun-Chun, et al.
Publicado: (2017) -
25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016) -
Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
por: Chiang, Kun-Chun, et al.
Publicado: (2014)